Skip to main content

About News Pricing Contact

News

September 30, 2026
Lantern & The Pediatric Cancer Imperative
The Story Behind Our Decision to Take LP‑184 Into Pediatric Cancers

Accelerating rare cancer research and drug development with AI-driven insights, comprehensive databases, and recursive agentic intelligence.

Developed by

Lantern Pharma Inc.
1920 McKinney Ave. 7th Floor
Dallas, TX 75201

Platform

Sign In
About

Support

Contact Us:
contact@withzeta.ai
Support:
contact@withzeta.ai

Company

Lantern Pharma
Careers

Legal

Terms of Service
Privacy Policy
Disclaimer
Responsible AI
Acceptable Use

© 2026 Lantern Pharma Inc.•Dallas, Texas

News | withZeta